Authors
Loading...
Randomized trial demonstrates IL-21's role in regulating effector CD8 T cells, controlling chronic infections, highlighting its therapeutic potential.
Zhao et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: